BACKGROUND: Polymyalgia rheumatica is one of the most common inflammatory rheumatologic conditions in older adults. Other inflammatory rheumatologic disorders are associated with an excess risk of vascular disease. We investigated whether polymyalgia rheumatica is associated with an increased risk of vascular events. METHODS: We used the General Practice Research Database to identify patients with a diagnosis of incident polymyalgia rheumatica between Jan. 1, 1987, and Dec. 31, 1999. Patients were matched by age, sex and practice with up to 5 patients without polymyalgia rheumatica. Patients were followed until their first vascular event (cardiovascular, cerebrovascular, peripheral vascular) or the end of available records (May 2011). All participants were free of vascular disease before the diagnosis of polymyalgia rheumatica (or matched date). We used Cox regression models to compare time to first vascular event in patients with and without polymyalgia rheumatica. RESULTS: A total of 3249 patients with polymyalgia rheumatica and 12 735 patients without were included in the final sample. Over a median follow-up period of 7.8 (interquartile range 3.3-12.4) years, the rate of vascular events was higher among patients with polymyalgia rheumatica than among those without (36.1 v. 12.2 per 1000 person-years; adjusted hazard ratio 2.6, 95% confidence interval 2.4-2.9). The increased risk of a vascular event was similar for each vascular disease end point. The magnitude of risk was higher in early disease and in patients younger than 60 years at diagnosis. INTERPRETATION: Patients with polymyalgia rheumatica have an increased risk of vascular events. This risk is greatest in the youngest age groups. As with other forms of inflammatory arthritis, patients with polymyalgia rheumatica should have their vascular risk factors identified and actively managed to reduce this excess risk.
BACKGROUND: Polymyalgia rheumatica is one of the most common inflammatory rheumatologic conditions in older adults. Other inflammatory rheumatologic disorders are associated with an excess risk of vascular disease. We investigated whether polymyalgia rheumatica is associated with an increased risk of vascular events. METHODS: We used the General Practice Research Database to identify patients with a diagnosis of incident polymyalgia rheumatica between Jan. 1, 1987, and Dec. 31, 1999. Patients were matched by age, sex and practice with up to 5 patients without polymyalgia rheumatica. Patients were followed until their first vascular event (cardiovascular, cerebrovascular, peripheral vascular) or the end of available records (May 2011). All participants were free of vascular disease before the diagnosis of polymyalgia rheumatica (or matched date). We used Cox regression models to compare time to first vascular event in patients with and without polymyalgia rheumatica. RESULTS: A total of 3249 patients with polymyalgia rheumatica and 12 735 patients without were included in the final sample. Over a median follow-up period of 7.8 (interquartile range 3.3-12.4) years, the rate of vascular events was higher among patients with polymyalgia rheumatica than among those without (36.1 v. 12.2 per 1000 person-years; adjusted hazard ratio 2.6, 95% confidence interval 2.4-2.9). The increased risk of a vascular event was similar for each vascular disease end point. The magnitude of risk was higher in early disease and in patients younger than 60 years at diagnosis. INTERPRETATION: Patients with polymyalgia rheumatica have an increased risk of vascular events. This risk is greatest in the youngest age groups. As with other forms of inflammatory arthritis, patients with polymyalgia rheumatica should have their vascular risk factors identified and actively managed to reduce this excess risk.
Authors: Kevin Barraclough; William G Liddell; Jennifer du Toit; Christopher Foy; Bhaskar Dasgupta; Mike Thomas; William Hamilton Journal: Fam Pract Date: 2008-08-07 Impact factor: 2.267
Authors: Bhaskar Dasgupta; Frances A Borg; Nada Hassan; Kevin Barraclough; Brian Bourke; Joan Fulcher; Jane Hollywood; Andrew Hutchings; Valerie Kyle; Jennifer Nott; Michael Power; Ash Samanta Journal: Rheumatology (Oxford) Date: 2009-11-12 Impact factor: 7.580
Authors: Cynthia S Crowson; Eric L Matteson; Elena Myasoedova; Clement J Michet; Floranne C Ernste; Kenneth J Warrington; John M Davis; Gene G Hunder; Terry M Therneau; Sherine E Gabriel Journal: Arthritis Rheum Date: 2011-03
Authors: Hilal Maradit Kremers; Megan S Reinalda; Cynthia S Crowson; Alan R Zinsmeister; Gene G Hunder; Sherine E Gabriel Journal: Arthritis Rheum Date: 2005-08-15
Authors: Hilal Maradit Kremers; Megan S Reinalda; Cynthia S Crowson; John M Davis; Gene G Hunder; Sherine E Gabriel Journal: Arthritis Rheum Date: 2007-03-15
Authors: F Atzeni; M Turiel; L Boccassini; S Sitia; L Tomasoni; M Battellino; A Marchesoni; V De Gennaro Colonna; P Sarzi-Puttini Journal: Reumatismo Date: 2011-11-09
Authors: Izzat Shbeeb; Divya Challah; Shafay Raheel; Cynthia S Crowson; Eric L Matteson Journal: Arthritis Care Res (Hoboken) Date: 2018-02-22 Impact factor: 4.794
Authors: F Buttgereit; T Brabant; H Dinges; I Hiemer; M Kaplani; U Kiltz; D Kyburz; A Reißhauer; M Schneider; C Weseloh; C Dejaco Journal: Z Rheumatol Date: 2018-06 Impact factor: 1.372
Authors: Sara Muller; Samantha L Hider; Toby Helliwell; Sarah Lawton; Kevin Barraclough; Bhaskar Dasgupta; Irena Zwierska; Christian D Mallen Journal: Arthritis Res Ther Date: 2016-09-07 Impact factor: 5.156
Authors: Edward Roddy; Sara Muller; Zoe Paskins; Samantha L Hider; Milisa Blagojevic-Bucknall; Christian D Mallen Journal: Medicine (Baltimore) Date: 2017-03 Impact factor: 1.889
Authors: Toby Helliwell; Sara Muller; Samantha L Hider; Irena Zwierska; Sarah Lawton; Jane Richardson; Christian Mallen Journal: Br J Gen Pract Date: 2018-11 Impact factor: 5.386
Authors: Sarah Louise Mackie; Gouri Koduri; Catherine L Hill; Richard J Wakefield; Andrew Hutchings; Clement Loy; Bhaskar Dasgupta; Jeremy C Wyatt Journal: RMD Open Date: 2015-08-13